Hester Biosciences Ltd

Hester Biosciences Ltd

₹ 1,633 0.69%
19 Apr - close price
About

Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry Vaccines, Poultry Health Products, Animal Vaccines and Animal Health Products, the company provides services like seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.[1]

Key Points

Business Segments

  • Market Cap 1,389 Cr.
  • Current Price 1,633
  • High / Low 1,940 / 1,293
  • Stock P/E 75.4
  • Book Value 331
  • Dividend Yield 0.49 %
  • ROCE 9.35 %
  • ROE 9.86 %
  • Face Value 10.0

Pros

  • Company has been maintaining a healthy dividend payout of 24.0%

Cons

  • Stock is trading at 4.93 times its book value
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
56.89 64.18 60.19 62.66 55.69 56.47 50.70 73.15 74.94 67.30 87.85 70.46 66.98
35.71 44.40 43.12 45.10 40.66 46.15 43.27 60.40 56.18 55.63 73.49 57.24 56.83
Operating Profit 21.18 19.78 17.07 17.56 15.03 10.32 7.43 12.75 18.76 11.67 14.36 13.22 10.15
OPM % 37.23% 30.82% 28.36% 28.02% 26.99% 18.28% 14.65% 17.43% 25.03% 17.34% 16.35% 18.76% 15.15%
1.27 -0.84 2.35 1.42 2.78 7.62 4.69 5.01 6.37 3.49 2.52 5.91 2.20
Interest 1.52 1.44 0.86 0.74 0.96 1.50 1.60 2.46 3.89 1.37 2.57 8.08 2.19
Depreciation 3.27 3.63 3.23 3.05 5.17 5.13 5.06 5.03 5.24 5.37 5.40 4.28 3.75
Profit before tax 17.66 13.87 15.33 15.19 11.68 11.31 5.46 10.27 16.00 8.42 8.91 6.77 6.41
Tax % 27.12% 27.18% 28.11% 26.73% 28.68% 20.34% 34.98% 35.74% 24.00% 32.19% 24.69% 40.18% 37.44%
12.87 10.10 11.02 11.13 8.33 9.00 3.56 6.60 12.16 5.71 6.71 4.04 4.02
EPS in Rs 14.52 11.39 14.68 12.48 9.97 9.07 4.67 8.16 13.15 5.33 6.90 4.81 4.68
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
48 65 69 90 101 123 136 178 183 214 235 266 293
30 43 44 64 67 82 89 110 128 146 175 215 243
Operating Profit 19 22 24 25 34 41 47 68 55 69 60 51 49
OPM % 39% 34% 36% 28% 34% 33% 35% 38% 30% 32% 26% 19% 17%
0 0 1 3 1 0 3 7 6 1 14 20 14
Interest 3 3 6 5 4 4 4 7 7 7 4 9 14
Depreciation 4 4 5 6 6 7 10 12 13 13 17 21 19
Profit before tax 12 14 13 18 25 31 36 57 41 50 54 40 31
Tax % 37% 37% 31% 26% 23% 26% 36% 28% 25% 31% 26% 30%
7 9 9 13 19 23 23 41 31 35 39 28 20
EPS in Rs 8.95 10.89 11.11 15.99 22.57 27.68 30.12 48.87 34.29 40.47 46.22 31.30 21.72
Dividend Payout % 7% 18% 18% 19% 18% 19% 33% 23% 19% 25% 22% 26%
Compounded Sales Growth
10 Years: 15%
5 Years: 14%
3 Years: 13%
TTM: 15%
Compounded Profit Growth
10 Years: 11%
5 Years: 3%
3 Years: -3%
TTM: -37%
Stock Price CAGR
10 Years: 33%
5 Years: 2%
3 Years: -9%
1 Year: -8%
Return on Equity
10 Years: 16%
5 Years: 16%
3 Years: 14%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 6 9 9 9 9 9 9 9 9 9 9 9 9
Reserves 54 59 66 76 93 113 132 169 193 220 251 271 273
16 32 48 55 59 66 69 90 121 110 228 274 273
19 24 19 20 25 25 35 32 65 73 74 116 128
Total Liabilities 95 124 142 160 186 213 244 299 387 411 562 670 683
39 38 54 60 65 102 110 145 142 133 237 259 248
CWIP 6 29 21 33 36 21 32 7 74 109 82 149 162
Investments -0 0 0 0 0 -0 -0 -0 -0 -0 21 25 28
50 57 68 68 85 89 102 148 170 169 222 237 245
Total Assets 95 124 142 160 186 213 244 299 387 411 562 670 683

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
14 12 9 20 19 35 38 47 37 58 9 24
-10 -23 -15 -21 -13 -30 -26 -21 -73 -42 -117 -77
-2 10 7 7 -7 2 -11 3 19 -18 112 42
Net Cash Flow 2 -1 2 5 -1 6 1 28 -17 -2 3 -12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 109 85 75 72 95 79 87 67 116 84 86 109
Inventory Days 1,351 736 1,145 431 627 376 505 540 834 452 424 399
Days Payable 199 135 145 68 109 84 100 93 261 204 101 141
Cash Conversion Cycle 1,261 685 1,074 434 614 371 491 514 690 332 409 367
Working Capital Days 204 137 194 158 188 145 150 153 169 172 204 203
ROCE % 20% 20% 18% 15% 19% 19% 20% 26% 16% 18% 14% 9%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73% 53.73%
0.58% 0.68% 0.80% 0.92% 0.72% 0.62% 0.45% 0.45% 0.45% 0.42% 0.43% 0.43%
0.40% 0.01% 0.02% 0.03% 0.04% 0.03% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00%
45.29% 45.58% 45.45% 45.31% 45.51% 45.60% 45.77% 45.81% 45.82% 45.84% 45.83% 45.84%
No. of Shareholders 16,10816,39916,26915,01713,43913,71113,39113,12012,98413,34213,45012,844

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls